Protein Phosphatase 2A inhibitor
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Protein Phosphatase 2A inhibitor, covering 2023-11-22 to 2023-11-22. Get the full timeline:
Most recent: Clinical Trial Update: Protein Phosphatase 2A Inhibitor, in Recurrent Glioblastoma [Phase 2]